- Home
- BEEP vs MCRB Comparison
BEEP vs MCRB Comparison
Compare BEEP & MCRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BEEP | MCRB |
|---|---|---|
| Founded | 2015 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 91.5M | 78.0M |
| IPO Year | 2021 | 2015 |
Fundamental Metrics
Financial Performance| Metric | BEEP | MCRB |
|---|---|---|
| Price | $2.04 | $7.65 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $6.50 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 56.2K | 38.5K |
| Earning Date | 05-12-2026 | 05-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $35,075,000.00 | $789,000.00 |
| Revenue This Year | $5.77 | N/A |
| Revenue Next Year | $22.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $1.76 | $6.56 |
| 52 Week High | $4.67 | $29.98 |
Technical Indicators
Market Signals| Indicator | BEEP | MCRB |
|---|---|---|
| Relative Strength Index (RSI) | 55.89 | 46.32 |
| Support Level | $1.89 | $7.33 |
| Resistance Level | $2.34 | $8.29 |
| Average True Range (ATR) | 0.26 | 0.43 |
| MACD | 0.04 | 0.05 |
| Stochastic Oscillator | 65.75 | 48.69 |
Price Performance
Historical ComparisonAbout BEEP Mobile Infrastructure Corporation
Mobile Infrastructure Corp focus on acquiring, owning and optimizing parking facilities and related infrastructure, including parking lots, parking garages, and other parking structures throughout the United States. It operates in a single reportable segment: parking. The parking segment derives revenue from managed property revenue and rental income at parking facilities. The company provides access to property and space for the parker's vehicle and charges fees that vary based on the level of usage. The company derives all of its revenue domestically.
About MCRB Seres Therapeutics Inc.
Seres Therapeutics Inc is a clinical-stage biotechnology company focused on the development of live biotherapeutic candidates. Its pipeline includes candidates such as SER-155 and SER-603, aimed at preventing and treating bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases. The company operates as a single reportable segment, mainly developing microbiome-based therapies targeting bacterial infections, antimicrobial resistance, and gastrointestinal immune diseases.